Safety and Efficacy of Tyrosine Kinase Inhibitors in Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

被引：0
|
作者：
Fatima, Farwah N.
Anwer, Faiz
Ali, Muhammad Ashar
Anwar, Muhammad Yasir
Khan, Sana
Ali, Rimsha
Aiman, Wajeeha
Javaid, Anum
Mumtaz, Aqsa
Mirza, Nayab
Hashmi, Hamza
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-135984
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Efficacy and safety of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia: a meta-analysis
    Xie, Bingqian
    Gao, Minjie
    Hu, Liangning
    Kong, Yuanyuan
    Gao, Lu
    Wang, Houcai
    Yang, Guang
    Zhang, Yiwen
    Tao, Yi
    Xu, Hongwei
    Zhan, Fenghuang
    Wu, Xiaosong
    Shi, Jumei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 1815 - 1821
  • [2] Safety and efficacy of tyrosine kinase inhibitors for the treatment of multiple sclerosis: A systematic review and meta-analysis from randomized controlled trials
    Yan, Zeya
    Gu, Feng
    Wang, Zilan
    Meng, Jiahao
    Tao, Xinyu
    Dai, Qiling
    Wang, Wei
    Liu, Meirong
    Wang, Zhong
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [3] Comparative efficacy and safety of first-line tyrosine kinase inhibitors in chronic myeloid leukemia: a systematic review and network meta-analysis
    Zhang, Jing-Jing
    Qian, Yu-Lan
    Wu, Zi-Yang
    Li, Yue
    Guan, Ying-Jie
    Sun, Cui
    Fu, Kai-Li
    Mei, Tong-Lin
    Goyal, Gaurav
    Bernasconi, Paolo
    Damiani, Daniela
    Zhu, Jian-Guo
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (07)
  • [4] Comparative efficacy and safety of tyrosine kinase inhibitors for chronic myeloid leukaemia: A systematic review and network meta-analysis
    Fachi, Mariana M.
    Tonin, Fernanda S.
    Leonart, Leticia P.
    Aguiar, Karina S.
    Lenzi, Luana
    Figueiredo, Bonald C.
    Fernandez-Llimos, Fernando
    Pontarolo, Roberto
    EUROPEAN JOURNAL OF CANCER, 2018, 104 : 9 - 20
  • [5] Efficacy and safety of second-generation FLT3 inhibitors in acute myeloid leukemia: A systematic review and meta-analysis of randomized controlled trials
    Lin, Wei-Ting
    Chao, Chien-Ming
    Lin, Cheng-Yao
    Hsu, Ya-Ting
    Hsiao, Sheng-Yen
    Weng, Teng-Song
    MOLECULAR AND CLINICAL ONCOLOGY, 2024, 21 (06)
  • [6] Efficacy and safety of tyrosine kinase inhibitors for advanced metastatic thyroid cancer: A systematic review and network meta-analysis of randomized controlled trials
    Zhao, Mingjian
    Li, Ruowen
    Song, Zhimin
    Miao, Chengxu
    Lu, Jinghui
    MEDICINE, 2024, 103 (15) : E37655
  • [7] Arterial Hypertension and Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis
    Mulas, Olga
    Caocci, Giovanni
    Mola, Brunella
    La Nasa, Giorgio
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [8] Clinical efficacy and safety of Janus kinase inhibitors for COVID-19: A systematic review and meta-analysis of randomized controlled trials
    Chen, Ching-Yi
    Chen, Wang-Chun
    Hsu, Chi-Kuei
    Chao, Chien-Ming
    Lai, Chih-Cheng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 99
  • [9] Clinical Benefits and Safety of FMS-Like Tyrosine Kinase 3 Inhibitors in Various Treatment Stages of Acute Myeloid Leukemia: A Systematic Review, Meta-Analysis, and Network Meta-Analysis
    Xu, Qingyu
    He, Shujiao
    Yu, Li
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] Efficacy and Safety of Mipomersen: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
    Fogacci, Federica
    Ferri, Nicola
    Toth, Peter P.
    Ruscica, Massimiliano
    Corsini, Alberto
    Cicero, Arrigo F. G.
    DRUGS, 2019, 79 (07) : 751 - 766
12345